Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 365 clinical trials
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

antihemophilic factor
factor ix
fitusiran
bethesda assay
severe haemophilia a
  • 0 views
  • 04 Dec, 2020
  • 11 locations
An Open-label Ascending Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 2-17 years with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) in order to identify the dose and regimen for adequate treatment of this population Secondary Objective: To describe the pharmacodynamic (PD) profile, the efficacy and the long-term safety of …

DMARD
sarilumab
arthritis
rheumatoid factor
disease modifying antirheumatic drugs
  • 0 views
  • 04 Dec, 2020
  • 33 locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

antihemophilic factor
factor ix
fitusiran
bethesda assay
severe haemophilia a
  • 0 views
  • 04 Dec, 2020
  • 6 locations
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 1-17 years with Systemic Juvenile Idiopathic Arthritis (sJIA) in order to identify the dose and regimen for adequate treatment of this population. Secondary Objective: To describe the pharmacodynamics (PD) profile, the efficacy, and the long term safety …

rheumatism
disease modifying antirheumatic drugs
fever
antirheumatic
rheumatic diseases
  • 0 views
  • 04 Dec, 2020
  • 30 locations
  • 0 views
  • 24 May, 2024
  • 2 locations
Stress Management and Biological Age in Breast Cancer Patients.RCT  

Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments. This study …

  • 0 views
  • 03 Oct, 2023
  • 13 locations
Study title (acronymtest)  

study overview

Accepts healthy volunteers
  • 0 views
  • 02 Mar, 2026
V6.3 Additional &QA123  

Test Comment here

  • 0 views
  • 24 Aug, 2023
  • 4 locations
The Effects of Functional Power Training on Frail and Pre-frail Community - Dwelling Older Adults in Singapore

To investigate the efficacy of a 12-week Functional Power Training (FPT) program in pre-frail and frail community-dwelling older adults in Singapore for the management of physical frailty.

  • 0 views
  • 05 Aug, 2020
Effect of MEDiterranean Diet on the microBIOME of Individuals With Type 2 Diabetes

Mediterranean diet has been indicated as a dietary pattern that promote the integrity of gut barrier and that has positive impact in the metabolic control of subjects with type 2 diabetes. This is a 12-week, single-arm clinical study that aims to evaluate if the effect of Mediterranean diet in metabolic …

microbiota
  • 0 views
  • 16 Feb, 2024
  • 1 location